로딩 중…
StockDiggingStockDigging

ClearPoint Neuro, Inc.

CLPT· NASDAQ
$10.69+0.00%
2026-10-30

Financials

Valuation Metrics

ClearPoint Neuro, Inc.'s Market Cap is $321M. At end of 2025 it was $387M. Ranked #2897 of 3,116 in US market (top 93%), #1305 of 1,472 on NASDAQ (top 89%), #183 of 203 in Health Care Equipment & Services (top 90%) by Market Cap.

Investment Metrics(as of 2026-10-30)

MetricValue
Size
Market Cap$321M
Revenue$45M
Net Income$-36M
Total Assets$113M
Net Assets$27M
Employees172
Value
P/B11.76x
P/S7.05x
FCF Yield-10.36%
Profitability
ROE-132.52%
ROA-32.05%
Op. Margin-70.56%
Revenue Growth32.51%
Financial Health
Debt Ratio313.42%
Total Debt$74M
FCF$-33M
Cash$46M
Current Ratio6.76x
Performance
1Y Return-54.86%
1M Return-12.45%
From 52W High-45.68%
1Y MDD-54.42%
Trading
Volume778,820 shares
Trading Value$8M
Per Share
EPS$-1.20
BPS$0.91

Company Info

CEO Joseph Michael Burnett
Employees 172
HQ Solana Beach, US

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.